Jasper Therapeutics Inc. (JSPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Operating Expenses | 14,119 | 6,008 | 328 | 229 | 0 |
| Operating Income | -14,119 | -6,008 | -328 | -229 | N/A |
| Interest Expense | 0 | 111 | 0 | 0 | 0 |
| Other Income | -4,779 | -4,706 | -3,106 | 1,715 | 0 |
| Pre-tax Income | -18,897 | -10,825 | -3,433 | 1,487 | 0 |
| Income Tax | N/A | N/A | 1 | 58 | N/A |
| Net Income Continuous | -18,838 | -10,825 | -3,434 | 1,429 | N/A |
| Net Income | $-18,838 | $-10,825 | $-3,434 | $1,429 | $N/A |
| EPS Basic Total Ops | 17.70 | -61.40 | -13.70 | 5.70 | N/A |
| EPS Basic Continuous Ops | 17.73 | -61.40 | -13.74 | 5.72 | N/A |
| EPS Diluted Total Ops | 17.70 | -61.40 | -13.70 | 5.70 | N/A |
| EPS Diluted Continuous Ops | 17.73 | -61.40 | -13.74 | 5.72 | N/A |
| EBITDA(a) | $-14,119 | $-6,008 | $-328 | $-229 | $N/A |